Trophos Launches First Study of Olesoxime in Multiple Sclerosis Patients
3/14/2013 11:48:24 AM
More...
|
Trophos Announces Positive Interim Review in Pivotal Study of Olesoxime in Spinal Muscular Atrophy
2/28/2013 10:58:04 AM
More...
|
Trophos Program Boosted by EUR 1 Million Grant for Olesoxime in Progressive Multiple Sclerosis
10/11/2012 10:47:47 AM
More...
|
Marceline Clementine Appointed Chief Financial Officer of Trophos
9/18/2012 9:31:24 AM
More...
|
Trophos Announces Conclusion of MitoTarget Consortium, Achieving Advanced Understanding of Neurodegenerative Diseases
7/31/2012 9:04:49 AM
More...
|
Trophos Appoints JSB-Partners as Global Partnership Advisor
7/23/2012 12:46:22 PM
More...
|
Trophos Appoints Christine Placet as Chief Executive Officer
6/12/2012 11:05:23 AM
More...
|
Actelion Ltd. (ALIOF.PK) Pulls Out of $250 Million Trophos Buy After ALS Drug Failure
12/14/2011 7:22:06 AM
More...
|
Trophos Initiates Phase II Proof of Concept Study for Novel Cardioprotective Compound, TRO40303, in Acute Myocardial Infarction
10/31/2011 9:22:35 AM
More...
|
Trophos Hosts Round-Table Meetings at ECTRIMS to Design POC Trial to Treat Progression in Multiple Sclerosis
10/25/2011 10:08:34 AM
More...
|
|